An Electrocardiogram Study to Evaluate the Effect of Vanzacaftor on the QT/QTc Interval in Healthy Participants

NCT05867147 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Vanzacaftor
DRUG: Vanzacaftor Placebo
DRUG: Moxifloxacin
DRUG: Moxifloxacin Placebo

Sponsor

Vertex Pharmaceuticals Incorporated